Cite
Effectiveness and safety of nivolumab in patients with advanced melanoma: A multicenter, observational study
MLA
Stéphane Dalle, et al. Effectiveness and Safety of Nivolumab in Patients with Advanced Melanoma: A Multicenter, Observational Study. Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....14f417395eb026535a482cd67ec9bacb&authtype=sso&custid=ns315887.
APA
Stéphane Dalle, Patrick Combemale, Yannick Le Corre, Caroline Dutriaux, E. Varey, Nathalie Beneton, Thomas Jouary, Caroline Robert, Henri Montaudié, Jean Philippe Arnault, Sandrine Monestier, Marie Thérèse Leccia, Sandrine Mansard, Laurent Mortier, Amir Khammari, Anne-Bénédicte Duval Modeste, François Skowron, Nicolas Meyer, Brigitte Dréno, … Sophie Dalac-Rat. (2021). Effectiveness and safety of nivolumab in patients with advanced melanoma: A multicenter, observational study.
Chicago
Stéphane Dalle, Patrick Combemale, Yannick Le Corre, Caroline Dutriaux, E. Varey, Nathalie Beneton, Thomas Jouary, et al. 2021. “Effectiveness and Safety of Nivolumab in Patients with Advanced Melanoma: A Multicenter, Observational Study,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....14f417395eb026535a482cd67ec9bacb&authtype=sso&custid=ns315887.